Rick Orr is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of therapeutic agents and active ingredient formulations. With a total of 4 patents to his name, Orr's work focuses on advancing medical treatments and delivery methods.

Latest Patents

One of Rick Orr's latest patents is titled "Oligonucleotide decoys for the treatment of pain." This invention provides therapeutic agents, specifically double-stranded nucleic acids known as oligonucleotide decoys. These agents are designed to modulate nociceptive signaling, offering potential solutions for preventing and treating pain. Another significant patent is "Formulations for the delivery of active ingredients." This invention relates to the in vivo delivery of active ingredient formulations, enhancing the effectiveness of treatments through innovative delivery methods.

Career Highlights

Throughout his career, Rick Orr has worked with various companies, including Adynxx, Inc. and Adynxx Sub, Inc. His work in these organizations has contributed to the development of cutting-edge medical technologies and therapeutic solutions.

Collaborations

Rick has collaborated with notable professionals in his field, including Julien Mamet and Scott Harris. These partnerships have fostered innovation and have been instrumental in advancing his research and inventions.

Conclusion

Rick Orr's contributions to the field of medical inventions and formulations highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to addressing significant medical challenges, particularly in pain management and drug delivery.

This text is generated by artificial intelligence and may not be accurate.